THER-09. ONCOLYTIC ADENOVIRUS, DNX-2401, FOR NAIVE DIFFUSE INTRINSIC PONTINE GLIOMAS: A PHASE I CLINICAL TRIAL

The objective of this trial is to determine the safety, tolerability, and toxicity of DNX-2401 in newly diagnosed DIPG patients (NCT03178032) followed by radiotherapy. Secondary endpoints are overall survival at 12 months, percentage of responses and induced immune response against tumor. Tumor biop...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Neuro Oncol
Main Authors: Iñigo-Marco, Ignacio, Gonzalez-Huarriz, Marisol, García-Moure, Marc, Tamayo, Ibon, Hervas, Sandra, Hernandez, Ruben, Buñales, Maria, DeAndrea, Carlos, Villalba, Maria, Jones, Chris, MacKay, Alan, Hulleman, Esther, Van der Lugt, Jasper, Aldave, Guillermo, Lopez-Ibor, Blanca, Patiño-Garcia, Ana, Diez-Valle, Ricardo, Fueyo, Juan, Gomez-Manzano, Candelaria, de Larraya, Jaime Gallego Perez, Tejada, Sonia, Alonso, Marta M
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Viral/Gene Therapy and other Novel Therapies
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7715674/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa222.859
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados